Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases

被引:639
作者
Buckner, Jane Hoyt [1 ]
机构
[1] Benaroya Res Inst, Translat Res Program, Seattle, WA 98101 USA
基金
美国国家卫生研究院;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; REMITTING MULTIPLE-SCLEROSIS; HUMAN PERIPHERAL-BLOOD; RHEUMATOID-ARTHRITIS; MEDIATED SUPPRESSION; CUTTING EDGE; IN-VITRO; ULCERATIVE-COLITIS; CROHNS-DISEASE; FUNCTIONAL-CHARACTERIZATION;
D O I
10.1038/nri2889
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
A lack of regulatory T (T-Reg) cells that express CD4, CD25 and forkhead box P3 (FOXP3) results in severe autoimmunity in both mice and humans. Since the discovery of T-Reg cells, there has been intense investigation aimed at determining how they protect an organism from autoimmunity and whether defects in their number or function contribute to the development of autoimmunity in model systems. The next phase of investigation - that is, to define the role that defects in T-Reg cells have in human autoimmunity - is now underway. This Review summarizes our progress so far towards understanding the role of CD4(+)CD25(+)FOXP3(+) T-Reg cells in human autoimmune diseases and the impact that this knowledge might have on the diagnosis and treatment of these diseases.
引用
收藏
页码:849 / 859
页数:11
相关论文
共 122 条
[81]
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease [J].
Saruta, Masayuki ;
Yu, Qj T. ;
Fleshner, Phillip R. ;
Mantel, Pierre-Yves ;
Schmidt-Weber, Carsten B. ;
Banham, Alison H. ;
Papadakis, Konstantinos A. .
CLINICAL IMMUNOLOGY, 2007, 125 (03) :281-290
[82]
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells [J].
Schneider, Anya ;
Rieck, Mary ;
Sanda, Srinath ;
Pihoker, Catherine ;
Greenbaum, Carla ;
Buckner, Jane H. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (10) :7350-7355
[83]
Basal lymphoid aggregates in ulcerative colitis colon:: a site for regulatory T cell action [J].
Sitohy, B. ;
Hammarstrom, S. ;
Danielsson, A. ;
Hammarstrom, M. -L. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (02) :326-333
[84]
Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO
[85]
2-M
[86]
Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids [J].
Suarez, A. ;
Lopez, P. ;
Gomez, J. ;
Gutierrez, C. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) :1512-1517
[87]
Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus [J].
Suen, Jau-Ling ;
Li, Hsiao-Ting ;
Jong, Yuh-Jyh ;
Chiang, Bor-Luen ;
Yen, Jeng-Hsien .
IMMUNOLOGY, 2009, 127 (02) :196-205
[88]
Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis:: Mechanism underlying unrestrained pathogenic effector T cell proliferation [J].
Sugiyama, H ;
Gyulai, R ;
Toichi, E ;
Garaczi, E ;
Shimada, S ;
Stevens, SR ;
McCormick, TS ;
Cooper, KD .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :164-173
[89]
Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO
[90]
2-Q